ICAM1 and Alzheimer disease: Furthermore, O'Bryant and colleagues found that TNF‐α and ICAM1, which were initially involved in the 18 plasma‐based proteins of Ray et al., could be biomarker candidates for the prediction of AD, as they were significantly elevated in the serum of AD subjects.86